| 000 | 01123 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516233337.0 | ||
| 264 | 0 | _c20151201 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1528-3658 | ||
| 024 | 7 |
_a10.2119/molmed.2014.00125 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoy, Ashbeel | |
| 245 | 0 | 0 |
_aCholinergic activity as a new target in diseases of the heart. _h[electronic resource] |
| 260 |
_bMolecular medicine (Cambridge, Mass.) _cJan 2015 |
||
| 300 |
_a527-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAcetylcholine _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAutonomic Nervous System |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHeart Diseases _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aGuatimosim, Silvia | |
| 700 | 1 | _aPrado, Vania F | |
| 700 | 1 | _aGros, Robert | |
| 700 | 1 | _aPrado, Marco A M | |
| 773 | 0 |
_tMolecular medicine (Cambridge, Mass.) _gvol. 20 _gp. 527-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2119/molmed.2014.00125 _zAvailable from publisher's website |
| 999 |
_c24192105 _d24192105 |
||